Dilatation left ventricular cavity dipyridamole imaging new marker triple-vessel disease significance mechanism dilatation left ventricular cavity dipyridamole imaging dipyridamole imaging dipyridamole radionuclide angiography patients known angiograms dipyridamole/delayed ratio left ventricular dimension image left ventricular dilatation ratio LVDR LVDR mean standard deviations patients coronary artery disease abnormal Twenty-two patients abnormal LVDR patients triple-vessel disease defect washout analysis sensitivity specificity patients triple-vessel disease whereas LVDR sensitivity specificity LVDR combination defect washout criteria sensitivity loss specificity patients abnormal LVDRs end-diastolic volume radionuclide angiography change dipyridamole infusion Dilatation left ventricular cavity dipyridamole imaging relative subendocardial hypoperfusion dipyridamole actual chamber enlargement LVDR sensitive specific triple-vessel disease complementary information imaging 